582 related articles for article (PubMed ID: 27305518)
1. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force.
Knudsen AB; Zauber AG; Rutter CM; Naber SK; Doria-Rose VP; Pabiniak C; Johanson C; Fischer SE; Lansdorp-Vogelaar I; Kuntz KM
JAMA; 2016 Jun; 315(23):2595-609. PubMed ID: 27305518
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force.
Knudsen AB; Rutter CM; Peterse EFP; Lietz AP; Seguin CL; Meester RGS; Perdue LA; Lin JS; Siegel RL; Doria-Rose VP; Feuer EJ; Zauber AG; Kuntz KM; Lansdorp-Vogelaar I
JAMA; 2021 May; 325(19):1998-2011. PubMed ID: 34003219
[TBL] [Abstract][Full Text] [Related]
3. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
[TBL] [Abstract][Full Text] [Related]
4. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Piper MA; Perdue LA; Rutter CM; Webber EM; O'Connor E; Smith N; Whitlock EP
JAMA; 2016 Jun; 315(23):2576-94. PubMed ID: 27305422
[TBL] [Abstract][Full Text] [Related]
5. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality.
D'Andrea E; Ahnen DJ; Sussman DA; Najafzadeh M
Cancer Med; 2020 Jan; 9(2):824-836. PubMed ID: 31777197
[TBL] [Abstract][Full Text] [Related]
6. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
Berger BM; Parton MA; Levin B
Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
[TBL] [Abstract][Full Text] [Related]
7. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
; Bibbins-Domingo K; Grossman DC; Curry SJ; Davidson KW; Epling JW; García FAR; Gillman MW; Harper DM; Kemper AR; Krist AH; Kurth AE; Landefeld CS; Mangione CM; Owens DK; Phillips WR; Phipps MG; Pignone MP; Siu AL
JAMA; 2016 Jun; 315(23):2564-2575. PubMed ID: 27304597
[TBL] [Abstract][Full Text] [Related]
8. Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model.
Piscitello A; Saoud L; Fendrick AM; Borah BJ; Hassmiller Lich K; Matney M; Ozbay AB; Parton M; Limburg PJ
PLoS One; 2020; 15(12):e0244431. PubMed ID: 33373409
[TBL] [Abstract][Full Text] [Related]
9. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
[TBL] [Abstract][Full Text] [Related]
11. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
[TBL] [Abstract][Full Text] [Related]
12. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
Knudsen AB; Hur C; Gazelle GS; Schrag D; McFarland EG; Kuntz KM
Ann Intern Med; 2012 Nov; 157(9):611-20. PubMed ID: 23128861
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.
Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Savarino JE; van Ballegooijen M; Kuntz KM; Zauber AG
J Natl Cancer Inst; 2010 Aug; 102(16):1238-52. PubMed ID: 20664028
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
